Molecular Typing Shows a High Level of HLA Class I Incompatibility in Serologically Well Matched Donor/Patient Pairs: Implications for Unrelated Bone Marrow.

Slides:



Advertisements
Similar presentations
WT1-specific T-cell responses in high-risk multiple myeloma patients undergoing allogeneic T cell–depleted hematopoietic stem cell transplantation and.
Advertisements

CXCL10-CXCR3 interactions play an important role in the pathogenesis of acute graft-versus-host disease in the skin following allogeneic stem-cell transplantation.
Comparable results of umbilical cord blood and HLA-matched sibling donor hematopoietic stem cell transplantation after reduced-intensity preparative regimen.
Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survival by Kai-Da Wu, Lisa.
In Vivo Tropism of Hepatitis C Virus Genomic Sequences in Hematopoietic Cells: Influence of Viral Load, Viral Genotype, and Cell Phenotype by Hervé Lerat,
Identification of alloreactive T-cell epitopes on the Rhesus D protein
Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants by.
by Hans G. Drexler, Roderick A. F. MacLeod, and Willy G. Dirks
In Stem Cell Transplantation by Limiting the Morbidity of Graft-versus-Host Disease Tolerance to Myeloablative Conditioning is Improved  Nicolas Novitzky,
by Andrew D. Redd, Ava Avalos, and Max Essex
Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant.
Effect of short-term interferon therapy on the outcome of subsequent HLA-identical sibling bone marrow transplantation for chronic myelogenous leukemia:
Expansion of NKG2A−LIR1− Natural Killer Cells in HLA-Matched, Killer Cell Immunoglobulin-Like Receptors/HLA-Ligand Mismatched Patients following Hematopoietic.
Nested Polymerase Chain Reaction With Sequence-Specific Primers Typing for HLA-A, -B, and -C Alleles: Detection of Microchimerism in DR-Matched Individuals.
Potential Role of a Mismatched HLA-Specific CTL Clone Developed Pre-Transplant in Graft Rejection following Cord Blood Transplantation  Hiroto Narimatsu,
Mutagenic potential of temozolomide in bone marrow cells in vivo
by Karthik A. Ganapathi, Danielle M. Townsley, Amy P. Hsu, Diane C
Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients.
Long-term expansion of effector/memory Vδ2− γδ T cells is a specific blood signature of CMV infection by Vincent Pitard, David Roumanes, Xavier Lafarge,
Ex vivo induction of multiple myeloma–specific cytotoxic T lymphocytes
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer by Jeffrey S. Miller, Yvette Soignier, Angela.
Coexistence of Two Functioning T-Cell Repertoires in Healthy Ex-Thalassemics Bearing a Persistent Mixed Chimerism Years After Bone Marrow Transplantation.
Immunologic evidence for lack of heterologous protection following resolution of HCV in patients with non–genotype 1 infection by Julian Schulze zur Wiesch,
Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative.
Analysis of clonotypic switch junctions reveals multiple myeloma originates from a single class switch event with ongoing mutation in the isotype-switched.
Interesting Case Conference
Cytomegalovirus-specific T cells are primed early after cord blood transplant but fail to control virus in vivo by Suzanne M. McGoldrick, Marie E. Bleakley,
The multidrug resistance-associated protein 3 (MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis in male.
Figure 1 HLA-haploidentical donors
Health-related quality of life of unrelated bone marrow donors in Japan by Mina Nishimori, Yoshitsugu Yamada, Keiko Hoshi, Yuichi Akiyama, Yasutaka Hoshi,
CD134-Allodepletion Allows Selective Elimination of Alloreactive Human T Cells without Loss of Virus-Specific and Leukemia-Specific Effectors  Xupeng.
National Marrow Donor Program HLA Matching Guidelines for Unrelated Adult Donor Hematopoietic Cell Transplants  Robert A. Bray, Carolyn K. Hurley, Naynesh.
Impact of Donor Characteristics and HLA Matching on Survival of Chinese Patients with Hematologic Malignancies Undergoing Unrelated Hematopoietic Stem.
Immune tolerance induction by nonmyeloablative haploidentical HSCT combining T-cell depletion and posttransplant cyclophosphamide by Franco Aversa, Esther.
Bromohydrin pyrophosphate enhances antibody-dependent cell-mediated cytotoxicity induced by therapeutic antibodies by Julie Gertner-Dardenne, Cecile Bonnafous,
Application of the ELISPOT assay to the characterization of CD8+ responses to Epstein-Barr virus antigens by Jie Yang, Victor M. Lemas, Ian W. Flinn, Chris.
HLA-A Disparities Illustrate Challenges for Ranking the Impact of HLA Mismatches on Bone Marrow Transplant Outcomes in the United States  Lee Ann Baxter-Lowe,
Major ABO Blood Group Mismatch Increases the Risk for Graft Failure after Unrelated Donor Hematopoietic Stem Cell Transplantation  Mats Remberger, Emma.
Outcomes of Patients with Myeloid Malignancies Treated with Allogeneic Hematopoietic Stem Cell Transplantation from Matched Unrelated Donors Compared.
Significance of Ethnicity in the Risk of Acute Graft-versus-Host Disease and Leukemia Relapse after Unrelated Donor Hematopoietic Stem Cell Transplantation 
Expansion of NKG2A−LIR1− Natural Killer Cells in HLA-Matched, Killer Cell Immunoglobulin-Like Receptors/HLA-Ligand Mismatched Patients following Hematopoietic.
Peripheral Blood Grafts from Unrelated Donors Are Associated with Increased Acute and Chronic Graft-versus-Host Disease without Improved Survival  Mary.
Haploidentical Transplantation Using T Cell Replete Peripheral Blood Stem Cells and Myeloablative Conditioning in Patients with High-Risk Hematologic.
Dynamic Detection of Anti–Human Leukocyte Antigen (HLA) Antibodies but not HLA-DP Loci Mismatches Can Predict Acute Graft-versus-Host Disease and Overall.
Successful Prevention of Acute Graft-versus-Host Disease Using Low-Dose Antithymocyte Globulin after Mismatched, Unrelated, Hematopoietic Stem Cell Transplantation.
Decreased Infections in Recipients of Unrelated Donor Hematopoietic Cell Transplantation from Donors with an Activating KIR Genotype  Marcie Tomblyn,
HLA DNA Typing and Transplantation
Marija Debeljak, Donald N. Freed, Jane A
Protective Immunity Transferred by Infusion of Cytomegalovirus-Specific CD8+ T Cells within Donor Grafts: Its Associations with Cytomegalovirus Reactivation.
Impact of HLA-DPB1 Haplotypes on Outcome of 10/10 Matched Unrelated Hematopoietic Stem Cell Donor Transplants Depends on MHC-Linked Microsatellite Polymorphisms 
Hematopoietic Cell Transplantation for Children with Acute Lymphoblastic Leukemia in Second Complete Remission: Similar Outcomes in Recipients of Unrelated.
Impact of Alemtuzumab Scheduling on Graft-versus-Host Disease after Unrelated Donor Fludarabine and Melphalan Allografts  Kile Green, Kim Pearce, Rob.
HLA-Mismatched, Noninherited Maternal Antigen–Matched Unrelated Cord Blood Transplantations Have Superior Survival: How HLA Typing the Cord Blood Donor's.
Functional analysis of clinical response to low-dose IL-2 in patients with refractory chronic graft-versus-host disease by Jennifer S. Whangbo, Haesook.
Stephen Leslie, Peter Donnelly, Gil McVean 
Identification of DPB1 Permissive Unrelated Donors Is Highly Likely
HLA-Allele Matched Unrelated Donors Compared to HLA-Matched Sibling Donors: Role of Cell Source and Disease Risk Category  Ann Woolfrey, Stephanie J.
by Esteban Arrieta-Bolaños, Pietro Crivello, Bronwen E
Potential Role of a Mismatched HLA-Specific CTL Clone Developed Pre-Transplant in Graft Rejection following Cord Blood Transplantation  Hiroto Narimatsu,
Unrelated Donor Hematopoietic Cell Transplantation: Factors Associated with a Better HLA Match  Jason Dehn, Mukta Arora, Stephen Spellman, Michelle Setterholm,
KIR Ligands and Prediction of Relapse after Unrelated Donor Hematopoietic Cell Transplantation for Hematologic Malignancy  Katharine C. Hsu, Ted Gooley,
Mixed chimerism established by hematopoietic stem cell transplantation is maintained by host and donor T regulatory cells by Francesca A. M. Kinsella,
Young Female Donors Do Not Increase the Risk of Graft-versus-Host Disease or Impact Overall Outcomes in Pediatric HLA-Matched Sibling Hematopoietic Stem.
Nonmyeloablative Peripheral Blood Haploidentical Stem Cell Transplantation for Refractory Severe Aplastic Anemia  Jennifer Clay, Austin G. Kulasekararaj,
Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival: A Retrospective.
Hematopoietic potential of HEP from patient-specific iPSC may be reduced. Hematopoietic potential of HEP from patient-specific iPSC may be reduced. (A)
Mismatched Related and Unrelated Donors for Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic Malignancies  Mary Eapen, Paul O'Donnell,
Likelihood of finding unrelated donor or cord blood
Likelihood of finding unrelated donor or cord blood
Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG.
Presentation transcript:

Molecular Typing Shows a High Level of HLA Class I Incompatibility in Serologically Well Matched Donor/Patient Pairs: Implications for Unrelated Bone Marrow Donor Selection by Iain Scott, John O’Shea, Mike Bunce, Jean-Marie Tiercy, J. Rafael Argüello, Helen Firman, John Goldman, H. Grant Prentice, Ann-Margaret Little, and J. Alejandro Madrigal Blood Volume 92(12):4864-4871 December 15, 1998 ©1998 by American Society of Hematology

Level of matching achieved by conventional typing methods. Level of matching achieved by conventional typing methods. Patients and potential donors were typed by serological methods for HLA-A and -B and DNA-based methods for HLA-DRB1 and -DQB1. Limiting dilution analysis was performed in the graft-versus-host direction to assess the frequency of host specific CTL precursors. Pairs with a high CTLp frequency (>1:105 PBMC) were judged to be mismatched at the cellular level. Iain Scott et al. Blood 1998;92:4864-4871 ©1998 by American Society of Hematology

HLA matching for bone marrow donor selection. HLA matching for bone marrow donor selection. DNA based typing (▪) showed an increased level of mismatching for HLA-A and -B over that defined by serology (░). Although no HLA-C serology was performed for original typing, DNA-based typing indicated a high level of incompatibility. Iain Scott et al. Blood 1998;92:4864-4871 ©1998 by American Society of Hematology

The effect of HLA-C mismatching on CTLp frequency. The effect of HLA-C mismatching on CTLp frequency. CTLp frequencies of 30 pairs with patient HLA-C locus incompatibilities are shown above. Mean CTLp frequencies differed significantly between those with only HLA-C mismatches (1:316,500) and those with further HLA class I mismatches (1:47,110). This indicates that HLA-C alloreactive T cells are found at a lower frequency than those at HLA-A and -B. The limit of sensitivity of this assay is 1 patient-specific donor CTLp/5 × 105 or higher. Mean CTLp frequencies differed significantly between groups according to the Mann-Whitney test. Iain Scott et al. Blood 1998;92:4864-4871 ©1998 by American Society of Hematology

DNA-based typing shows many HLA class I mismatches in the high CTLp frequency group not identified using serological methods. DNA-based typing shows many HLA class I mismatches in the high CTLp frequency group not identified using serological methods. (▪) Matched pairs; (░) those with detected HLA class I mismatches. Forty-seven donors had high (>1:105) patient-specific CTLp frequencies. Only 8 (17%) of these had HLA class I mismatches detected by serological typing, reflecting the low overall number of HLA class I serological mismatched pairs. The proportion of HLA class I mismatched pairs in the high CTLp frequency group increased to 23 (49%) after DNA-based typing, with 21 pairs mismatched at the HLA-B and/or -A locus. However, 24 pairs (51%) with high CTLp frequencies appear to be compatible for HLA class I. Iain Scott et al. Blood 1998;92:4864-4871 ©1998 by American Society of Hematology

Multiple mismatches are shown by high resolution HLA class I typing. Multiple mismatches are shown by high resolution HLA class I typing. (▪) Original matching level; (░) the matching level obtained after DNA typing for HLA class I. After serological testing for HLA-A, -B and DNA typing for HLA-DRB1, -DQB1, 92% of pairs fell in the 0 or 1 mismatch group. This was reduced to 69% after DNA typing of HLA-A, -B, and -C. The increase in pairs with 3 or more mismatches increased from 2% to 16%, reflecting the association of HLA subtypes on different haplotypes. Iain Scott et al. Blood 1998;92:4864-4871 ©1998 by American Society of Hematology